Patrizia Felicetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax\|Flu study protocol	BMJ OPEN	2023
Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation	FRONTIERS IN DRUG SAFETY AND REGULATION	2023
THESHINISS-VAX: VACCINI A MRNA COVID-19 E MIOCARDITE/PERICARDITE IN SOGGETTI CON MALATTIA REUMATICA IN ITALIA	ISTISAN CONGRESSI	2023
Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy: a multi-database, self-controlled case series study	PLOS MEDICINE	2022
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines	PHARMACEUTICALS	2022
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database	DRUG SAFETY	2022
The Italian Approach to Improve Standard Quality of ICSRs for COVID 19 Vaccines: From Patient Data to Causality Assessment	DRUG SAFETY	2022
Vasculitic peripheral neuropathy: Case definition and guidelines for collection, analysis, and presentation of immunisation safety data	VACCINE	2017
Kawasaki disease and immunisation: A systematic review	VACCINE	2017
Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases	VACCINE	2016
Vasculitis as an adverse event following immunization – Systematic literature review	VACCINE	2016